drugset / Trial / NCT05195710

Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases

NCT05195710

Phase 1 Recruiting 50 enrolled M.D. Anderson Cancer Center Sirtex Medical · collab
NaSingle-groupOpen-labelTreatment

Summary

A prospective, interventional study evaluating the safety of Y-90 TARE for tumor control of the right side and induction of left liver hypertrophy as part of a planned single-stage or two-stage hepatectomy for patients with CLM and insufficient FLR at the time of presentation.

Timeline

Start
2022-11-16
Primary completion
2028-03-31
Completion
2028-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Yttrium-90 Other / unclassified

Indications